United States · FDA National Drug Code directory
ENTECAVIR
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-426_697e4e32-4c50-4b6d-a1ee-b547f0c4ef1c
- Product NDC
- 69097-426
- Form
- TABLET, FILM COATED
- Composition / generic term
- ENTECAVIR
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20161206
- Source listing expiry
- 20271231
Source-listed ingredients
- ENTECAVIR — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-426-02) · 69097-426-02
- 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-426-05) · 69097-426-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →